Novo Holdings Acquires Catalent for $16.5 Billion
December 18, 2024
Novo Holdings A/S agreed to acquire Catalent, Inc. in an all-cash transaction valued at approximately $16.5 billion ($63.50 per share). The deal was later completed, and Catalent became a private company under Novo Holdings ownership; Novo Nordisk subsequently acquired Catalent’s three fill-finish sites in Italy, Indiana (USA), and Belgium.
- Buyers
- Novo Holdings A/S, Novo Nordisk A/S
- Targets
- Catalent, Inc.
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.